• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    Infinity Pharmaceuticals, Inc. (INFI)

    -NasdaqGS
    16.51 Up 0.34(2.10%) Mar 5, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 164,995   -   47,114  
    Cost of Revenue -   -   -  
    Gross Profit 164,995   -   47,114  
    Operating Expenses
    Research Development143,633  99,760  118,595  
    Selling General and Administrative29,285  27,916  (18,673)
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (7,923) (127,676) (52,808)
    Income from Continuing Operations
    Total Other Income/Expenses Net339  896  752  
    Earnings Before Interest And Taxes(7,584)(126,780)(52,056)
    Interest Expense9,649   -  1,908  
    Income Before Tax(17,233)(126,780)(53,964)
    Income Tax Expense183   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(17,416)(126,780)(53,964)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (17,416) (126,780) (53,964)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (17,416) (126,780) (53,964)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.